For: | Liang ZY, Kang X, Chen H, Wang M, Guan WX. Effect of Clostridium perfringens enterotoxin on gastric cancer cells SGC7901 which highly expressed claudin-4 protein. World J Gastrointest Oncol 2017; 9(4): 153-159 [PMID: 28451062 DOI: 10.4251/wjgo.v9.i4.153] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v9/i4/153.htm |
Number | Citing Articles |
1 |
Lihini Ranesha Weerakkody, Chamindri Witharana. The role of bacterial toxins and spores in cancer therapy. Life Sciences 2019; 235: 116839 doi: 10.1016/j.lfs.2019.116839
|
2 |
Saman Soleimanpour, Seyed Mahdi Hasanian, Amir Avan, Atieh Yaghoubi, Majid Khazaei. Bacteriotherapy in gastrointestinal cancer. Life Sciences 2020; 254: 117754 doi: 10.1016/j.lfs.2020.117754
|
3 |
Anna Piontek, Miriam Eichner, Denise Zwanziger, Laura‐Sophie Beier, Jonas Protze, Wolfgang Walther, Sarah Theurer, Kurt Werner Schmid, Dagmar Führer‐Sakel, Jörg Piontek, Gerd Krause. Targeting claudin‐overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin. Molecular Oncology 2020; 14(2): 261 doi: 10.1002/1878-0261.12615
|
4 |
Rina Fujiwara-Tani, Shiori Mori, Ruiko Ogata, Rika Sasaki, Ayaka Ikemoto, Shingo Kishi, Masuo Kondoh, Hiroki Kuniyasu. Claudin-4: A New Molecular Target for Epithelial Cancer Therapy. International Journal of Molecular Sciences 2023; 24(6): 5494 doi: 10.3390/ijms24065494
|
5 |
Wei Liu, Meijin Li. The role of claudin-4 in the development of gastric cancer. Scandinavian Journal of Gastroenterology 2020; 55(9): 1072 doi: 10.1080/00365521.2020.1795923
|
6 |
Dewu Lin, Xiaolan Feng, Bingjie Mai, Xin Li, Fei Wang, Jiexi Liu, Xin Liu, Kun Zhang, Xiaobing Wang. Bacterial-based cancer therapy: An emerging toolbox for targeted drug/gene delivery. Biomaterials 2021; 277: 121124 doi: 10.1016/j.biomaterials.2021.121124
|
7 |
Keng Ye, Zunjin Ke, Xijiong Zhang, Ke Liang, Qi Zhang, Jianhong Huang. Bacterial Peptides and Bacteriocins as Novel Treatment for Prostate Cancer. International Journal of Peptide Research and Therapeutics 2023; 29(5) doi: 10.1007/s10989-023-10544-z
|
8 |
Lan Su, Rui Yang, Yanan Sheng, Saif Ullah, Yuheng Zhao, Hu Shunjiayi, Zhuo Zhao, Qingjing Wang. Insights into the oral microbiota in human systemic cancers. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1369834
|
9 |
Claire M. Doocey, Karen Finn, Craig Murphy, Caitriona M. Guinane. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development. BMC Microbiology 2022; 22(1) doi: 10.1186/s12866-022-02465-6
|
10 |
Elke Burgermeister, Matthias P. Ebert. Microbiome in Gastrointestinal Cancer. 2023; : 41 doi: 10.1007/978-981-19-4492-5_4
|
11 |
Atieh Yaghoubi, Majid Khazaei, Saba Jalili, Seyed Mahdi Hasanian, Amir Avan, Saman Soleimanpour, William C. Cho. Bacteria as a double-action sword in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(1): 188388 doi: 10.1016/j.bbcan.2020.188388
|
12 |
Atieh Yaghoubi, Kiarash Ghazvini, Majid Khazaei, Seyed Mahdi Hasanian, Amir Avan, Saman Soleimanpour. The use of Clostridium in cancer therapy: a promising way. Reviews and Research in Medical Microbiology 2022; 33(2): 121 doi: 10.1097/MRM.0000000000000281
|
13 |
Kendra J Royston, Babatunde Adedokun, Olufunmilayo I Olopade. Race, the microbiome and colorectal cancer. World Journal of Gastrointestinal Oncology 2019; 11(10): 773-787 doi: 10.4251/wjgo.v11.i10.773
|
14 |
Chinemerem P. Ogbu, Sourav Roy, Alex J. Vecchio. Disruption of Claudin-Made Tight Junction Barriers by Clostridium perfringens Enterotoxin: Insights from Structural Biology. Cells 2022; 11(5): 903 doi: 10.3390/cells11050903
|